Tumor genotype determines susceptibility to oncolytic herpes simplex virus mutants: strategies for clinical application.
Tumor genotype determines susceptibility to oncolytic herpes simplex virus mutants: strategies for clinical application. Future Oncol. 2007 Oct; 3(5):545-56.